Work

Doravirine/islatravir (DOR-ISL) as a new once-daily oral single-tablet regimen for human immunodeficiency virus (HIV) treatment: unmet need or paradox of choice?

Year: 2026

Type: article

Source: Annals of Translational Medicine

DOI: 10.21037/atm-2026-0134

Authors: Amit C Achhra, Onyema E Ogbuagu

Institution: Yale University

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7224084390

FWCI:

Cites:

Cited by:

Related to: 10